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52 rain. A subset of dogs (n - 4) had imeglng for 90 mln. Rediclabeled 
micmsphores were injected at the time of IPPA injection and before sacrifice. 
RA flow [% normal zone (Nl)] remained constant dudng the experiment 
(initial: 80 -~ 3,3%: late: 77 :b 3.3%, p ,, 0.58). Reconstructed SPECT short 
axis Images were quantified using circumferential count profiles and RA IPPA 
activity expressed as %NL Initial RA IPPA activity (7'9.4- 2.1%) was similar to 
the initial flow deficit (p = 0.78). However, at 52 rain after IPPA tnjeet;on the 
RA IPPA deficit had normalized (97 • 3.3%, n ,, 6) relative to initial RA IPPA 
activity (p ,, 0.01), and initial RA flow (p = 0.01). Myocardial IPPA clserenoe 
fTom RA and NI regions are shown for 4 dogs imaged for 90 min. Significant 
"normalization" of the defect occuned within 12 mtn post IPPA injection (p ,, 
0.03). 
Thus, measurement of myocardial IPPA clearance with dynamic SPEDT 
imaging can potentially ider~Ify ischemlc viable myoserdium accurately and 
as early as 12 min post injection. 
Nuclear Teatlng In Patients With High ~ n  
Llkelllzood of CAD or Previous MI: is There 
Benefit From Added Prognostic Value? 
Rory Hachamovltch, Daniel S. Barman, Hosen Kiat, ishao Cohen, J. 
Arthur C.,ablco, Amen Amanullah, John Friedman, George A, Diamond. 
Cedar~-Sinai Medica~ Center, Los Angeles, C~wiiomia 
"me enhanced stratification or benefit from added prognostic value of nuclear 
testing in patients with a high likelihood of CAD (hl'ah L~; Iz; no', known. Thus, 
we identified 2190 consecutive patients (pts) with high prescan Lk or previous 
MI who underwent rest TI/stress Tc-99m sestamibi dual isotope myocardial 
partus,'on SPEOT (DIMP$) and were followed for at least 1 year (yr} for 
events [cardiac death (CO), non.fatal myo~,ardial nfarctton(MI)]. DIMPS was 
visually assessed using 20 segments cored on a 5 point scale (0 = normal, 4 
= no uptake) and rest and stress scores were used to calculate the summed 
stress score (SSS), summed rest score ($R$), and summed ifference score 
(SDS = (SSS-SR$)). Results: During a moan foflow-up eriod of 1.8 :E 0.7 
years, 158 events occurred (91 M I and 67 CD), and 246 pts were censored for 
early revascu!arizatlan. Using a stepwIse Cox proportional hazards model, 
we found that pro-scan Lk and history ct CAD yielded significant inforrnation 
(x ~ = 12). SSS, the most predic6va nuclear variable, added significant further 
information (x = increased tO 56, p < 0.0001 ). Pts with normal scans had 0 .'P/= 
event rate in the first year (n = 425, 0,'P/, CD, 0% MI). Over this same time) 
period, pts with mffdly and severely abnormal scans were at similar isk for MI 
(11 = 471, 1048, 3.2%. 3.3% raspeetivaly). The dsk for CD was greater in pts 
with severely abnormal scans than mildly abnonnal scans (2.5% vs. 0.8%, 
p < 0.05). 898 of 1944 pts were reclassified by normal or mildly abnomlal 
scans as low dsk for CO by DIMPS. 
Conclusion: DIMP$ added significant incremental prognsalio value over 
clinical information alone in pts with high Lk of CAD or prior MI end reclassified 
46% of pts as low risk for cardiac death. 
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• Pulmonary Vascular Endothelial Function Is 
Depressed in Experimental Pulrnunary Embolism 
William L. Daisy, G.V.R,K. Sharma. West Roxbury VA Medical Center and 
Harvard Medical School, Boston, MA 
The role of endotheflum-dorlved relaxing factor (EDRF) In modulating pul- 
monary vascular reactivity was examined in experimental pulmonary em- 
bolism (PE) by Intrapatmonary infusions of asetyloholine (ACH) and n]tm- 
gly~rin (NTG). PE was orealed in 14 mongrel dogs by injecting autclogous 
thmmbin-cinfo into the jugular vein. Selective clna angiograms oi a segmental 
pulmonary artery (PA) were obtained after |nfualon of graded concantmtions 
j 9 ~1"1}1 t~fANOVA i'i 
of ACH (10 "e to 10 -s M) followed by NTG Into the PA before and after PE. 
Percent change in the PA diameter was measured using digital calipers. 
Dose response curves obtained from mean values for control and after each 
infusion of ACH are displayed. 
Reeutts: Infusion of ACH before PE (control) prodtced a dose dependent 
vasodifatstlon. Incontrast, AGH infusion after PE pnxlucod minimal change 
in PA diameter. (p ,, < 0.01 control vs. PE). However, infusion of NTG after 
PE produced pulmonary vesodllatatlon, indicating preserved endothallurn- 
independent vesodllalaflan. Conclusion: ACH mediated EDRF release from 
the pulmonary vascular endothellum is impaired in experimental polmonanl 
embolism. 
Effect o! Ollfedng Thromboplsstin Reagents end 
Lab instrumentation on INR I)etermleatlons for 
Patients Reealving Therapeutic Intensity 
Anticeagulant Therapy 
Nan K. Jasabson, Harvey S. Hahn, Lan T. Truong, Anita L McManus, 
David R. Ferry, Madlyn A. Johnston. Loma IJnda VAMC, Loma Llncte, CA; 
Hamiffon Civic Hospitals Research Center, Ontario, Canada 
Expanding indications for oral anticoagulant therapy have increased the need 
for reliable mon'~dng of astlcoagulant effect. The prothrombin time has 
been the standard test of anticoagulant intensity and is routinely reported 
as an International Normalized Ratio (INR) to compensate for differences In 
thmmboplasfln reagent sensitivities. To determine the expected varfation in 
INR determinations due to the different reagents and coagulation instruments 
utilized in clinical aboratories In North America, we prospectively collected 
serum samples fiom 50 unselectsd patients receiving wadadn therapy. For 
each patient sample, the INR was determined with each of 5 reagents 
(Intsmational Sensitivity Index (ISl) values ranging from 1.03 to 1.96) and 
on each of 3 instruments. The following table demonstrates the vadatlon 
in individual patient INR values obtained with diffsrent reagant/instmment 
cOmblnaflons at differing levels of anticoagulant intensity' demonstrating the 
increased variation due to instrumentation: 
Mean INR across Range of INR valueS Range of INR valueS 
reagents a~ reagents a..~oss Instruments 
2.5 2.1-3.1 1.9-8.3 
3.5 3,0-4.8 2.5--4.8 
4.5 3.8-3.2 3.2--5.4 
6,0 4.1-8.3 3.6-9.6 
Conclusion: Currently aveitebte commercial thmmboplastin reagents and 
coagulation ]nstn~ments allow for cliok:ally significant variation in INR deter- 
mtn~ttans across the spectrum of combinations available. This has significant 
implkT.atians both for the clinical management of patients and for the interpre- 
tation of research results. 
~ Thrombolytic Therapy Is • Premising Therapeutl© 
Option for Patients With Renal Arteriel Embolism 
Oiolflch C. Gufba, Raft Llechand, Miohaal Preus, Fdedrich tuft, 
Rainer Dlalz. Franz-Volhard Klinik, Humboldt Unh, ersity Beff/n, Germany 
Renal arterial embolism (RAE) is a rare, but severe manifestation of arterial 
embollc disease. With thrombolysls iT), if applied early, however, renal artsrj 
patsnoy may be restored and major abdominal surgnry and loss of renal 
function can be prevented. Currently, only 25 cases of RAE and T are 
reported In the I~reture. We report from 17 consecutive patients (IOLS) with 
anglographlcally proven RAE, who were treated with either rt-PA La. (n ,, 
12) (2 mg bolus and 1.5 mg/h for 12 h) or uroklnase I.a. (n = 5) (100.000 IU 
bolus and 100,000 IU/h for 12 h). Successful reperfuslon was achieved in 15 
tots (88%), Complete restoration of renal function however, as demonstrated 
by crealinlna ,znd szinttgraphio studies, was observed in only 6 pts (35%), 
paTllal impalrme,~t el renal fun~on In 8 pts (4"P/o) and complete loss of 
renal function in 3 (18%). Gross haen~turia occured in all 15 pts (100%) 
successfully repan'used. The incidence of major hasmorrhage was 12% (2 
pts). No fatal or cerebral h~.emorrhage was observed. It is of Importanse to 
mention, that after restoration of renal blood flow a period of 7 Io 10 days 
with severe renal dysfunction was a constant indinrj In all patients before the 
k~dnays finally recovered, Creatinino and BUN increased from pretreatl/teflt 
141 =t: 77 to a maximum value 612.4- 202 mmoBl on day 5 and 12,3 =1= 6,8 
to 40.8 -E 11.6 mmoVI respectively. They finally retomed ~ to 187 =t: 141 
mmol/I (Dreallnine) and 16.1 4* 9,3 mmol/I (BUN) on day 14, 
Conclusion: If diagnosis of RAE is set up in time and T is initiated early, 
reperfusion is possible in > 80%, reeulfing in good recovery of renal function 
in the majority of pts. T in RAE there/ore seems an effective therapeutic 
option with an acceptably low hasmorrhaglo risk. 
